A review of blinding in randomized controlled trials found results inconsistent and questionable

被引:68
作者
Boutron, I [1 ]
Estellat, C
Ravaud, P
机构
[1] INSERM, U738, F-75018 Paris, France
[2] Grp Hosp Bichat Claude Bernard, Dept Epidemiol Biostat & Rech Clin, F-75018 Paris, France
[3] Univ Paris 07, Fac Xavier Bichat, F-75018 Paris, France
关键词
double-blind method; randomized controlled trials; methods; standards; research design; single-blind method;
D O I
10.1016/j.jclinepi.2005.04.006
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: To determine methods to assess the success of blinding in randomized controlled trials (RCTs). Methods: We searched MEDLINE, the Cochrane Controlled Trials Register, and the Cochrane Method Register and performed a manual search to target studies that attempt to assess blinding and describe the methods used in those studies. Results: A total of 90 reports were selected. Reports assessed the success of blinding participants (n = 58), care providers (n = 36), and outcome assessors (n = 15). Of the 58 reports assessing the success of blinding participants, 54 (93%) reported asking participants to guess their treatment assignment. There was no consistency in timing of assessment (e.g., once at the end of the trial, 57%, or several times during the trial, 26%) or modalities of answering (e.g., "do not know" answers, 43%, or participants forced to guess, 31%). A statistical analysis was performed in 57% of reports. The statistical analysis mainly compared the proportion of correct guesses to those produced by chance (32%) or checked for a relation between participants' guesses and treatment assignment (23%). Conclusions: Methods of assessing the success of blinding, analysis and reporting the results were inconsistent and questionable. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1220 / 1226
页数:7
相关论文
共 32 条
[21]  
McRae C, 2004, ARCH GEN PSYCHIAT, V61, P627
[22]   In the dark - The reporting of blinding status in randomized controlled trials [J].
Montori, VM ;
Bhandari, M ;
Devereaux, PJ ;
Manns, BJ ;
Ghali, WA ;
Guyatt, GH .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (08) :787-790
[23]   THE IMPACT OF BLINDING ON THE RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED MULTIPLE-SCLEROSIS CLINICAL-TRIAL [J].
NOSEWORTHY, JH ;
EBERS, GC ;
VANDERVOORT, MK ;
FARQUHAR, RE ;
YETISIR, E ;
ROBERTS, R .
NEUROLOGY, 1994, 44 (01) :16-20
[24]   Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate - A randomized, double-blind, placebo-controlled trial [J].
Prasad, AS ;
Fitzgerald, JT ;
Bao, B ;
Beck, FWJ ;
Chandrasekar, PH .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :245-252
[25]   Turning a blind eye - Why we don't test for blindness at the end of our trials [J].
Sackett, DL .
BRITISH MEDICAL JOURNAL, 2004, 328 (7448) :1136-1136
[26]   EMPIRICAL-EVIDENCE OF BIAS - DIMENSIONS OF METHODOLOGICAL QUALITY ASSOCIATED WITH ESTIMATES OF TREATMENT EFFECTS IN CONTROLLED TRIALS [J].
SCHULZ, KF ;
CHALMERS, I ;
HAYES, RJ ;
ALTMAN, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (05) :408-412
[27]  
Schulz KF, 1996, BRIT MED J, V312, P742
[28]   Blinding in randomised trials: hiding who got what [J].
Schulz, KF ;
Grimes, DA .
LANCET, 2002, 359 (9307) :696-700
[29]   Turning a blind eye - Authors have blinkered view of blinding [J].
Senn, SJ .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7448) :1135-1136
[30]  
SHAPIRO S, 2004, BMJ 0224